Pityriasis rosea (PR) is an acute, self-limiting exanthematous disease associated with the
endogenous systemic reactivation of human herpesvirus (HHV)-6 and/or HHV-7. The …

Skin disease due to viruses may be a primary infection of the epidermis or may arise
secondary to systemic infection. Depending on the virus, the effects may be necrotic damage …

Pityriasis rosea (PR) is a common erythemato-squamous dermatosis which almost always,
is easily diagnosed. Mostly the disease presents in its classical form. However, clinical …

Pityriasis rosea (PR) is a benign papulosquamous disorder seen commonly in clinical
practice. Despite its prevalence and benign nature, there are still times when this common …

Several exanthems including Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical
periflexural exanthem, eruptive pseudoangiomatosis, and papular-purpuric gloves and …

To assess the prevalence of relapses of pityriasis rosea (PR), a retrospective cohort study
investigated all PR cases diagnosed in Genoa between 2000 and 2013 and followed them …

Background Pityriasis rosea is a scaly, itchy rash that mainly affects young adults and lasts
for 2 to 12 weeks. The effects of many available treatments are uncertain. This is an update …

Pityriasis rosea is a common acute exanthema of unknown aetiology, which causes severe
anxiety. In this study, the demographic data of pityriasis rosea patients, who presented to our …

Pityriasis rosea is a common papulo-squamous disorder, which has gained significant
importance in the last decade, especially in the context of its possible viral etiology. In this …

Purpose: To evaluate the efficacy and safety of short-course low-dose oral prednisolone in
symptomatic pityriasis rosea (PR) of onset< 5 days and compare it with placebo. Material …